We create value.
aXichem is an innovative biotechnology company specialising in development of natural analogue ingredients.
aXichem is a Swedish public limited liability company with its registered office in Lund. The company’s share has been listed on Nasdaq First North since 2013. Responsibility for the governance, management and control of aXichem is shared between the shareholders at the Annual General Meeting (AGM), the company’s Board of Directors and Chief Executive Officer and regulated by the Swedish Companies Act and applicable Articles of Association.